Claims for Patent: 7,262,298
✉ Email this page to a colleague
Summary for Patent: 7,262,298
| Title: | 4-hydroxybenzomorphans |
| Abstract: | 4-Hydroxybenzomorphans containing carboxamide or thiocarboxamide at the 3-position are useful as analgesics, anti-diarrheal agents, anticonvulsants, antitussives and anti-addiction medications. |
| Inventor(s): | Mark P. Wentland |
| Assignee: | Rensselaer Polytechnic Institute |
| Application Number: | US11/266,651 |
| Patent Claims: |
1. A compound of formula: wherein A is chosen from —C(═O)NH2 and —C(═S)NH2; R2 and R2a are both hydrogen or taken together R2 and R2a are ═O; R3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R4 is chosen from hydrogen, hydroxy, amino, lower alkoxy, C1–C20 alkyl and C1–C20 alkyl substituted with hydroxy or carbonyl; R11 is hydrogen; R12 is chosen from hydrogen, hydroxy, lower alkoxy and —NR13R14; or together, R11 and R12 form a carbonyl or a vinyl substituent; R13 and R14 are chosen independently from hydrogen and C1 to C7 hydrocarbon; and the dotted line represents an optional double bond. 2. A compound according claim 1 wherein R2 and R2a are hydrogen; R3 is chosen from hydrogen, cyclopropyl, and cyclobutyl, vinyl and tetrahydrofuranyl; R4 is chosen from hydrogen and hydroxyl; R11 is hydrogen; R12 is chosen from hydrogen and hydroxy; or together, R11 and R12 form a carbonyl. 3. A compound according to claim 1 of formula: wherein R2 and R2a are both hydrogen or taken together R2 and R2a are ═O; R3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R4 is chosen from hydrogen, hydroxy, amino, lower alkoxy, C1–C20 alkyl and C1–C20 alkyl substituted with hydroxy or carbonyl; R11 is hydrogen; R12 is chosen from hydrogen, hydroxy, lower alkoxy and —NR13R14; or together, R11 and R12 form a carbonyl or a vinyl substituent; R13 and R14 are chosen independently from hydrogen and C1 to C7 hydrocarbon; and the dotted line represents an optional double bond. 4. A compound according to claim 3 wherein: R2 and R2a are hydrogen; R3 is chosen from hydrogen, cyclopropyl, and cyclobutyl, vinyl and tetrahydrofuranyl; R4 is chosen from hydrogen and hydroxyl; R11 is hydrogen; R12 is chosen from hydrogen and hydroxy; or together, R11 and R12 form a carbonyl. 5. A compound according to claim 4 selected from the group of 6. A compound according to claim 1 of formula: wherein R2 and R2a are both hydrogen or taken together R2 and R2a are ═O; R3 is chosen from hydrogen, lower alkyl, alkenyl, aryl, heterocyclyl, benzyl and hydroxyalkyl; R4 is chosen from hydrogen, hydroxy, amino, lower alkoxy, C1–C20 alkyl and C1–C20 alkyl substituted with hydroxy or carbonyl; R11 is hydrogen; R12 is chosen from hydrogen, hydroxy, lower alkoxy and —NR13R14; or together, R11 and R12 form a carbonyl or a vinyl substituent; R13 and R14 are chosen independently from hydrogen and C1 to C7 hydrocarbon; and the dotted line represents an optional double bond. 7. A compound according to claim 6 wherein: R2 and R2a are hydrogen; R3 is chosen from hydrogen, cyclopropyl, and cyclobutyl, vinyl and tetrahydrofuranyl; R4 is chosen from hydrogen and hydroxyl; R11 is hydrogen; R12 is chosen from hydrogen and hydroxy; or together, R11 and R12 form a carbonyl. 8. The compound of formula according to claim 5. |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
